Edgewood Management LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 29.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 736,292 shares of the medical equipment provider's stock after selling 306,657 shares during the period. Intuitive Surgical accounts for approximately 4.8% of Edgewood Management LLC's portfolio, making the stock its 8th biggest position. Edgewood Management LLC owned about 0.21% of Intuitive Surgical worth $299,398,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Bank of America Corp DE lifted its holdings in shares of Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock valued at $1,667,388,000 after buying an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in Intuitive Surgical in the second quarter worth approximately $1,335,753,000. Amundi increased its holdings in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after buying an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock valued at $970,635,000 after acquiring an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its position in Intuitive Surgical by 10.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider's stock valued at $769,948,000 after acquiring an additional 184,044 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.
Latest Intuitive Surgical News
Investors following ISRG have been watching these news items:
- Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
- Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
- Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, Director Gary Guthart sold 20,095 shares of the company's stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the transaction, the director owned 1,204,530 shares of the company's stock, valued at approximately $543,977,793.30. This represents a 1.64% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig Barratt sold 1,150 shares of the firm's stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the transaction, the director owned 1,150 shares in the company, valued at approximately $529,000. This represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 39,363 shares of company stock valued at $17,738,749 in the last three months. 0.60% of the stock is currently owned by corporate insiders.
Intuitive Surgical Stock Performance
Shares of ISRG stock opened at $399.06 on Friday. The stock has a market cap of $138.33 billion, a price-to-earnings ratio of 48.25, a P/E/G ratio of 3.02 and a beta of 1.45. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The firm has a fifty day moving average of $423.51 and a 200-day moving average of $427.91.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm's revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.40 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.
Wall Street Analyst Weigh In
Several analysts have commented on ISRG shares. KeyCorp reissued an "overweight" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. TD Cowen restated a "buy" rating and set a $485.00 price target on shares of Intuitive Surgical in a report on Monday, October 19th. Raymond James Financial reaffirmed an "outperform" rating and issued a $480.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Wednesday, October 21st. Finally, Robert W. Baird increased their target price on shares of Intuitive Surgical from $513.00 to $550.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $495.90.
Check Out Our Latest Stock Analysis on ISRG
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.